title: Methodological issues in a comparative study of ziprasidone and risperidone.
authors.forename: Georges M
authors.initials: GM
authors.lastname: Gharabawi
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Bossie
authors.forename: Ramy
authors.initials: R
authors.lastname: Mahmoud
authors.forename: Carla M
authors.initials: CM
authors.lastname: Canuso
authors.forename: Robert A
authors.initials: RA
authors.lastname: Lasser
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Turkoz
authors.forename: Andrew
authors.initials: A
authors.lastname: Greenspan
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design / Q000592:standards*; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone; D018967:Risperidone